Adiponectin expression in epicardial adipose tissue after percutaneous coronary intervention with bare-metal stent;Expressão gênica de adiponectina no tecido adiposo epicárdico após intervenção coronária percutânea com implante de stent metálico

Brazilian Journal of Cardiovascular Surgery

Volumn 26, Issue 3, 2011, Pages 427-432

  Spener, Roberta França ^a   Breda, João Roberto ^a   Pires, Adilson Casemiro ^a   Pinhal, Maria Aparecida da Silva ^a   do Souto, Ricardo Peres ^a  

^a FMABC ^*

Author keywords

Adiponectin; Angioplasty; Coronary restenosis; Percutaneous coronary; Transluminal

Indexed keywords

ADIPONECTIN; AUTACOID;

ADIPOSE TISSUE; ARTICLE; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PERICARDIUM; RESTENOSIS; STENT;

ADIPONECTIN; ADIPOSE TISSUE; CORONARY RESTENOSIS; GENE EXPRESSION; HUMANS; INFLAMMATION MEDIATORS; PERICARDIUM; STENTS;

EID: 81355154168     PISSN: 01027638     EISSN: 16789741     Source Type: Journal    
DOI: 10.5935/1678-9741.20110018     Document Type: Article

References (25)

1. Gaspardone A, Versaci F. Coronary stenting and inflammation. Am J Cardiol. 2005;96(12A):65L-70L.
2. Iacobellis G, Pistilli D, Gucciardo M, Leonetti F, Miraldi F, Brancaccio G, et al. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine. 2005;29(6):251-5.
3. Sacks HS, Fain JN. Human epicardial adipose tissue: a review. Am Heart J. 2007;153(6):907-17.
4. Rabkin SW. Epicardial fat: properties, function and relationship to obesity. Obes Rev. 2007;8(3):253-61.
5. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab. 2000;11(8):327-32.
6. Hutley L, Prins JB. Fat as an endocrine organ: relationship to the metabolic syndrome. Am T Med Sci. 2005;330(6):280-9.
7. Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med. 2005;2(10):536-43.
8. Cheng KH, Chu CS, Lee KT, Lin TH, Hsieh CC, Chiu CC, et al. Adipocytokines and proinflamatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes (Lond). 2008;32(2):268-74.
9. Eiras S, Teijeira-Fernández E, Shamagian LG, Fernandez AL, Vazquez-Boquete A, Gonzales-Juanatey JR. Extension of coronary artery disease is associated with increased IL-6 expression and decreased adiponectin gene expression in epicardial adipose tissue. Cytokine. 2008;43(2):174-80.
10. Iacobellis G, Cotesta D, Petramala L, De Santis V, Vitale D, Tritapepe L, et al. Intracoronary adiponectin levels rapidly and significantly increase after coronary revascularization. Int J Cardiol. 2010;144(1):160-3.
11. Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003;108(20):2460-6.
12. Iglesias MJ, Eiras S, Piñeiro R, Lópes-Otero D, Gallego R, Fernández AL, et al. Gender differences in adiponectin and leptin expression in epicardial and subcutaneous adipose tissue. Findings in patients undergoing cardiac surgery. Rev Esp Cardiol. 2006;59(12):1252-60.
13. Baker AR, Silva NF, Quinn DW, Harte AL, Pagano D, Bonser RS, et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol. 2006;5:1.
14. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev. 2000;21(6):697-738.
15. Baker AR, Harte AL, Howell N, Pritlove DC, Ranasinghe AM, da Silva NF, et al. Epicardial adipose tissue as a source of nuclear factor-kappaB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease. J Clin Endocrinol Metab. 2009;94(1):261-7.
16. Piñeiro R, Iglesias MJ, Gallego R, Raghay K, Eiras S, Rubio J, et al. Adiponectin is synthesized and secreted by human and murine cardiomyocytes. FEBS Lett. 2005;579(23):5163-9.
17. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokyne regulating glucose and lipid metabolism. Trends Endocrinol Metab. 2002;13(2):84-9.
18. Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol. 2003;148(3):293-300.
19. Beltowski J. Adiponectin and resistin: new hormones of white adipose tissue. Med Sci Monit. 2003;9(2):RA55-61.
20. Fantuzzi G. Adipose tissue, adipokynes, and inflammation. J Allergy Clin Imunnol. 2005;115(5):911-9.
21. Gomes WJ, Gianotti Filho O, Catani R, Paez RP, Hossne NA, Buffolo E. Alterações inflamatórias das artérias coronárias e do miocárdio induzidas por stents coronários. Rev Bras Cir Cardiovasc. 2002;17(4):292-8.
22. Gomes WJ, Braile DM. Estudo Syntax: análise e implicações clínicas. Rev Bras Cir Cardiovasc. 2008;23(4):III-IV.
23. Gomes WJ, Buffolo E. Cirurgia de revascularização miocárdica após intervenção coronária percutânea. Podemos obter os mesmos resultados? Rev Bras Cir Cardiovasc. 2006;21(4):V-VIII.
24. Fragomeni LSM, Falleiro RP, Hoppen G, Krahl G. Revascularização cirúrgica do miocárdio em pacientes com stents coronários. Rev Bras Cir Cardiovasc. 2005;20(4):371-6.
25. Gomes WJ, Buffolo E. Stent coronário e inflamação. Rev Bras Cir Cardiovasc. 2003;18(4):III-VI.